Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults

PHASE1UnknownINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DEVICE

treatment by HLPFC coil

"DTMS treatment will be given for 3 weeks, 5 days a week. Before each DTMS treatment, neural network excitation practice will be done using AttenGo software (AttenGo, Herzlia, Israel).~Each treatment day: Follow-up to evaluate clinical side effects of treatment. Two additional meetings with DTMS treatment and follow-up will be held to evaluate the efficacy of treatment and side effects. The first will be four weeks after the end of the daily treatment phase; the second eight weeks after the end of the daily treatment phase."

Trial Locations (1)

Unknown

RECRUITING

Tel-Aviv Sourasky Medical Center, Tel Aviv

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Brainsway

INDUSTRY

NCT01196910 - Deep Transcranial Magnetic Stimulation (DTMS) as a Treatment for Attention Deficit Hyperactivity Disorder (ADHD) in Adults | Biotech Hunter | Biotech Hunter